Open AccessComparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
Author(s) -
Rajvardhan Azad,
Siddarth Sain,
Yog Raj Sharma,
Deepankur Mahajan
Publication year - 2012
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.106100
Subject(s) - medicine , acetonide , triamcinolone acetonide , ophthalmology , refractory (planetary science) , diabetic macular edema , visual acuity , macular edema , intraocular pressure , bevacizumab , randomized controlled trial , diabetic retinopathy , surgery , diabetes mellitus , chemotherapy , physics , astrobiology , endocrinology
In spite of laser being the gold standard treatment for Diabetic Macular edema (DME), some patients do not respond to laser. Various treatment modalities are being tried in the management of refractory diffuse DME (DDME).